Clinical trial NCT00468481 - References

Contraception — Efficacy and Safety Study for an Oral Contraceptive Containing Folate

Citation(s)

•   Bart S Sr, Marr J, Diefenbach K, Trummer D, Sampson-Landers C
  Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based mu
•   Campone M, Berton-Rigaud D, Joly-Lobbedez F, Baurain JF, Rolland F, Stenzl A, Fabbro M, van Dijk M, Pinkert J, Schmelter T, de Bont N, Pautier P
  A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the pr
•   Castaño PM, Aydemir A, Sampson-Landers C, Lynen R
  The folate status of reproductive-aged women in a randomised trial of a folate-fortified oral contraceptive: dietary and blood assessments. Public Health Nutr. 2014 Jun;17(6):1375-83. doi: 10.1017/S136898
•   Taylor TN, Farkouh RA, Graham JB, Colligs A, Lindemann M, Lynen R, Candrilli SD
  Potential reduction in neural tube defects associated with use of Metafolin-fortified oral contraceptives in the United States. Am J Obstet Gynecol. 2011 Nov;205(5):460.e1-8.

Multi-Center, Randomized, Double-Blind Active-Controlled, Parallel Group Study to Investigate Plasma Folate, Red Blood Cell Folate and Homocysteine Levels During a 24 Week Oral Administration of an OC Containing Folate Compared to OC Alone

Details for clinical trial NCT00468481